ACA
GOSS icon

Apis Capital Advisors’s Gossamer Bio GOSS Stock Holding History

Apis Capital Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-180,000
Closed -$216K – 25
2023
Q2 		$216K Buy
+180,000
New +$224K 0.22% 29

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Apis Capital Advisors's GOSS Position: Q3 2023 in Review

Apis Capital Advisors sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 180,000 shares — an estimated $216K sold.

Apis Capital Advisors first reported a position in GOSS in Q2 2023 and held it in 1 quarter. The position peaked at $216K in Q2 2023. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Apis Capital Advisors reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Apis Capital Advisors sold 180,000 Gossamer Bio shares in Q3 2023, an estimated $216K.
  • Apis Capital Advisors first reported a position in Gossamer Bio in Q2 2023 and held it in 1 quarter.
  • Apis Capital Advisors's Gossamer Bio position peaked at $216K in Q2 2023.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Apis Capital Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.